Alternative Foods London Ltd. Filleted Accounts Cover |
Company No. 11299079 | |||||||||
Alternative Foods London Ltd. Directors Report Registrar |
The Directors present their report and the accounts for the year ended 31 March 2025. | |||||||||
Principal activities | |||||||||
Directors | |||||||||
The Directors who served at any time during the year were as follows: | |||||||||
H.L. Carter | |||||||||
M. Carter | |||||||||
C. Cormier | |||||||||
P. Mason | |||||||||
J. Olsen | |||||||||
Signed on behalf of the board | |||||||||
P. Mason | |||||||||
Director | |||||||||
31 March 2025 | |||||||||
Alternative Foods London Ltd. Balance Sheet Registrar |
at | ||||||||||
Company No. | Notes | 2025 | 2024 | |||||||
£ | £ | |||||||||
Fixed assets | ||||||||||
Intangible assets | 4 | |||||||||
Tangible assets | 5 | |||||||||
Current assets | ||||||||||
Stocks | 6 | |||||||||
Debtors | 7 | |||||||||
Cash at bank and in hand | ||||||||||
Creditors: Amount falling due within one year | 8 | ( | ( | |||||||
Net current assets | ||||||||||
Total assets less current liabilities | ||||||||||
Creditors: Amounts falling due after more than one year | 9 | ( | ( | |||||||
Net assets | ||||||||||
Capital and reserves | ||||||||||
Called up share capital | ||||||||||
Share premium account | 11 | |||||||||
Revaluation reserve | 11 | |||||||||
Profit and loss account | 11 | ( | ( | |||||||
Total equity | ||||||||||
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account. | ||||||||||
Approved by the board on 31 March 2025 and signed on its behalf by: | ||||||||||
P. Mason | ||||||||||
Director | ||||||||||
31 March 2025 | ||||||||||
Alternative Foods London Ltd. Notes to the Accounts Registrar |
for the year ended 31 March 2025 | ||||||||||||||
1 | General information | |||||||||||||
Alternative Foods London Ltd. is a private company limited by shares and incorporated in England and Wales. | ||||||||||||||
Its registered number is: 11299079 | ||||||||||||||
Its registered office is: | ||||||||||||||
2 | Accounting policies | |||||||||||||
Turnover | ||||||||||||||
Revenue from the sale of goods is recognised when all the following conditions are satisfied: • the Company has transferred to the buyer the significant risks and rewards of ownership of the goods; • the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold; • the amount of revenue can be measured reliably; • it is probable that the economic benefits associated with the transaction will flow to the Company; and • the costs incurred or to be incurred in respect of the transaction can be measured reliably. Specifically, revenue from the sale of goods is recognised when goods are delivered and legal title is passed. | ||||||||||||||
Intangible fixed assets | ||||||||||||||
Tangible fixed assets and depreciation | ||||||||||||||
At each balance sheet date, the company reviews the carrying amount of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss. | ||||||||||||||
Plant and machinery | ||||||||||||||
Motor vehicles | ||||||||||||||
Furniture, fittings and equipment | ||||||||||||||
Research and development costs | ||||||||||||||
Expenditure on research and development is written off in the year it is incurred unless it meets the criteria to allow it to be capitalised. Costs of research are always written off in the year in which they are incurred. Where development costs are recognised as an asset, they are amortised over the period expected to benefit from them. Amortisation of the capitalised costs begins once the developed product comes into use, typically at rate of 33.33% straight line. | ||||||||||||||
Research and Development Tax credit | ||||||||||||||
During the financial year, Alternative Foods London Ltd received a tax credit for qualifying research and development expenditure under the Research and Development Tax relief scheme. This is presented as a tax repayment in the Statement of Profit or Loss in line with disclosure requirements under FRS 102. | ||||||||||||||
Freehold investment property | ||||||||||||||
No depreciation is provided in respect of investment properties. | ||||||||||||||
Investments | ||||||||||||||
Stocks | ||||||||||||||
When stocks are sold, the carrying amount of those stocks is recognised as an expense in the period in which the related revenue is recognised. The amount of any write-down of stocks to net realisable value and all losses of stocks are recognised as an expense in the period in which the write-down or loss occurs. The amount of any reversal of any write-down of stocks is recognised as a reduction in the amount of inventories recognised as an expense in the period in which the reversal occurs. Work in progress is reflected in the accounts on a contract by contract basis by recording revenue and related costs as contract activity progresses. | ||||||||||||||
Trade and other debtors | ||||||||||||||
Trade and other creditors | ||||||||||||||
Foreign currencies | ||||||||||||||
Leased assets | ||||||||||||||
Leases which do not transfer substantially all the risks and rewards of ownership to the Company are classified as operating leases. Assets held under finance leases are initially recognised as assets of the Company at their fair value at the inception of the lease or, if lower, at the present value of the minimum lease payments. The corresponding liability to the lessor is included in the balance sheet date as a finance lease obligation. Lease payments are apportioned between finance expenses and reduction of the lease obligation so as to achieve a constant rate of interest on the remaining balance of the liability. Finance expenses are recognised immediately in profit or loss, unless they are directly attributable to qualifying assets, in which case they are capitalised in accordance with the Company's policy on borrowing costs (see the accounting policy above). Assets held under finance leases are depreciated in the same way as owned assets. Operating lease payments are recognised as an expense on a straight-line basis over the lease term. In the event that lease incentives are received to enter into operating leases, such incentives are recognised as a liability. The aggregate benefit of incentives is recognised as a reduction of rental expense on a straight-line basis. | ||||||||||||||
Defined contribution pensions | ||||||||||||||
The contributions are recognised as expenses when they fall due. Amounts not paid are shown in accruals in the balance sheet. The assets of the plan are held separately from the company in independently administered funds. | ||||||||||||||
Provisions | ||||||||||||||
Provisions are charged as an expense to the profit and loss account in the year that the Company becomes aware of the obligation, and are measured at the best estimate at balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties. When payments are eventually made, they are charged to the provision carried in the balance sheet. | ||||||||||||||
3 | Employees | |||||||||||||
2025 | 2024 | |||||||||||||
Number | Number | |||||||||||||
The average monthly number of employees (including directors) during the year was: | ||||||||||||||
4 | Intangible fixed assets | |||||||||||||
Patents and trade-marks | Total | |||||||||||||
£ | £ | |||||||||||||
Cost | ||||||||||||||
At 1 April 2024 | ||||||||||||||
At 31 March 2025 | ||||||||||||||
Amortisation and impairment | ||||||||||||||
At 1 April 2024 | ||||||||||||||
Charge for the year | ||||||||||||||
Disposals | ||||||||||||||
At 31 March 2025 | ||||||||||||||
Net book values | ||||||||||||||
At 31 March 2025 | ||||||||||||||
At 31 March 2024 | ||||||||||||||
5 | Tangible fixed assets | |||||||||||||
Plant and machinery | Motor vehicles | Fixtures, fittings and equipment | Total | |||||||||||
£ | £ | £ | £ | |||||||||||
Cost or revaluation | ||||||||||||||
At 1 April 2024 | ||||||||||||||
Additions | ||||||||||||||
At 31 March 2025 | ||||||||||||||
Depreciation | ||||||||||||||
At 1 April 2024 | ||||||||||||||
Charge for the year | ||||||||||||||
Disposals | ||||||||||||||
At 31 March 2025 | ||||||||||||||
Net book values | ||||||||||||||
At 31 March 2025 | ||||||||||||||
At 31 March 2024 | 354,146 | 5,749 | 14,816 | |||||||||||
6 | Stocks | |||||||||||||
2025 | 2024 | |||||||||||||
£ | £ | |||||||||||||
Raw materials and consumables | ||||||||||||||
Finished goods | ||||||||||||||
7 | Debtors | |||||||||||||
2025 | 2024 | |||||||||||||
£ | £ | |||||||||||||
Trade debtors | ||||||||||||||
VAT recoverable | ||||||||||||||
Other debtors | ||||||||||||||
Prepayments and accrued income | ||||||||||||||
8 | Creditors: | |||||||||||||
amounts falling due within one year | ||||||||||||||
2025 | 2024 | |||||||||||||
£ | £ | |||||||||||||
Bank loans and overdrafts | ||||||||||||||
Trade creditors | ||||||||||||||
Taxes and social security | ( | |||||||||||||
Other creditors | ||||||||||||||
Accruals and deferred income | ||||||||||||||
9 | Creditors: | |||||||||||||
amounts falling due after more than one year | ||||||||||||||
2025 | 2024 | |||||||||||||
£ | £ | |||||||||||||
Bank loans and overdrafts | ||||||||||||||
Obligations under finance lease and hire purchase contracts | ||||||||||||||
10 | Share Capital | |||||||||||||
At the balance sheet date the company had 2,021,133 Ordinary shares and 34,461 B Ordinary shares in issue. | ||||||||||||||
11 | Reserves | |||||||||||||
Revaluation Reserve | Total other reserves | |||||||||||||
£ | £ | |||||||||||||
At 1 April 2023 | ||||||||||||||
Movement on revaluation reserve | ||||||||||||||
At 31 March 2024 and 1 April 2024 | ||||||||||||||
At 31 March 2025 | ||||||||||||||
earnings as these have been detailed earlier within the financial statements. The company revaluation reserve represents the equity fair value of financial instruments held at the year end. The Company has provided a share options scheme. The fair value of such share options is calculated on the grant date and recognised within administrative expenses, on a straight-line basis throughout the option's vesting periods. The cost is accumulated within the share option reserve within equity until the options are exercised (and the relevant shares are issued) or the options lapse. | ||||||||||||||